Zhao J - Search Results

1

Is response evaluation criteria in solid tumors (RECIST) effective in patient selection for radical resection after neoadjuvant immunotherapy with advanced NSCLC?

Xu Y, Ma D, Qin Y, Li S, Li J, Jiang Y, Wang M, Xu Y, Zhao J, Chen M, Cheng W, Hu K, Liu H. Xu Y, et al. Among authors: zhao j. Thorac Cancer. 2023 Jun;14(17):1635-1639. doi: 10.1111/1759-7714.14909. Epub 2023 Apr 24. Thorac Cancer. 2023. PMID: 37094918 Free PMC article.

2

Circulating tumor cells PD-L1 expression detection and correlation of therapeutic efficacy of immune checkpoint inhibition in advanced non-small-cell lung cancer.

Zhou Q, Liu X, Li J, Tong B, Xu Y, Chen M, Liu X, Gao X, Shi Y, Zhao J, Zhong W, Wang M. Zhou Q, et al. Among authors: zhao j. Thorac Cancer. 2023 Feb;14(5):470-478. doi: 10.1111/1759-7714.14767. Epub 2023 Jan 11. Thorac Cancer. 2023. PMID: 36630992 Free PMC article.

3

Comparison of Chemotherapy Plus Pembrolizumab vs. Chemotherapy Alone in EGFR-Mutant Non-small-Cell Lung Cancer Patients.

Chen M, Xu Y, Zhao J, Liu X, Liu X, Zhang D, Shi Y, Zhang L, Zhong W, Wang M. Chen M, et al. Among authors: zhao j. Clin Lung Cancer. 2023 May;24(3):278-286. doi: 10.1016/j.cllc.2022.12.003. Epub 2022 Dec 28. Clin Lung Cancer. 2023. PMID: 36635116 Free article.

4

Characterization of driver mutations in Chinese non-small cell lung cancer patients using a novel targeted sequencing panel.

Zhao J, Wu Y, Chen MJ, Xu Y, Zhong W, Wang MZ. Zhao J, et al. J Thorac Dis. 2022 Dec;14(12):4669-4684. doi: 10.21037/jtd-22-909. J Thorac Dis. 2022. PMID: 36647494 Free PMC article.

5

Study protocol of KeyPemls-004: A phase 2 study of pembrolizumab in combination with plinabulin and docetaxel in previously treated patients with metastatic non-small cell lung cancer and progressive disease (PD) after immunotherapy (PD-1/PD-L1 inhibitor) alone or in combination with platinum-doublet chemotherapy.

Liu J, Chen M, Gao X, Liu X, Zhao J, Pan R, Zhong W, Xu Y, Wang M. Liu J, et al. Among authors: zhao j. Thorac Cancer. 2023 Mar;14(8):773-778. doi: 10.1111/1759-7714.14806. Epub 2023 Feb 1. Thorac Cancer. 2023. PMID: 36725772 Free PMC article.

6

Osimertinib Improves overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastases.

Ye Q, Xu Y, Zhao J, Gao X, Chen M, Pan R, Zhong W, Wang M. Ye Q, et al. Among authors: zhao j. Transl Oncol. 2023 May;31:101637. doi: 10.1016/j.tranon.2023.101637. Epub 2023 Mar 2. Transl Oncol. 2023. PMID: 36867956 Free PMC article.

7

Gut microbiota composition in patients with advanced malignancies experiencing immune-related adverse events.

Liu X, Tang H, Zhou Q, Zeng Y, Lu B, Chen D, Li Y, Qian J, Chen M, Zhao J, Xu Y, Wang M, Tan B. Liu X, et al. Among authors: zhao j. Front Immunol. 2023 Feb 20;14:1109281. doi: 10.3389/fimmu.2023.1109281. eCollection 2023. Front Immunol. 2023. PMID: 36891304 Free PMC article.

8

All-shot Aspirations in Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) Are Associated With Malignancy.

Sun X, Zhang T, Shao C, Wang P, Chen M, Zhao J, Wang M. Sun X, et al. Among authors: zhao j. Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231169881. doi: 10.1177/15330338231169881. Technol Cancer Res Treat. 2023. PMID: 37078145 Free PMC article.

9

Dynamic gut microbiota changes in patients with advanced malignancies experiencing secondary resistance to immune checkpoint inhibitors and immune-related adverse events.

Zeng Y, Shi Q, Liu X, Tang H, Lu B, Zhou Q, Xu Y, Chen M, Zhao J, Li Y, Qian J, Wang M, Tan B. Zeng Y, et al. Among authors: zhao j. Front Oncol. 2023 Apr 11;13:1144534. doi: 10.3389/fonc.2023.1144534. eCollection 2023. Front Oncol. 2023. PMID: 37114123 Free PMC article.

10

Vitamin D Status Is Associated With Immune Checkpoint Inhibitor Efficacy and Immune-related Adverse Event Severity in Lung Cancer Patients: A Prospective Cohort Study.

You W, Liu X, Tang H, Lu B, Zhou Q, Li Y, Chen M, Zhao J, Xu Y, Wang M, Qian J, Tan B. You W, et al. Among authors: zhao j. J Immunother. 2023 Jul-Aug 01;46(6):236-243. doi: 10.1097/CJI.0000000000000469. Epub 2023 May 16. J Immunother. 2023. PMID: 37184520

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57,737 results

Search Page

Filters